Overview & Mechanism
Activates GLP-1 receptors to increase glucose-dependent insulin secretion, slow gastric emptying, and reduce appetite.
Research Dosage
Titrate 0.6 mg โ 1.2 mg โ 1.8 mg โ 3.0 mg once daily
Subcutaneous injection
Once daily
12+ weeks
Reconstitution & Storage
Comes pre-formulated in pens; for research vials, reconstitute per concentration with bacteriostatic water.
Refrigerate 2โ8 ยฐC. Do not freeze.
Safety & Side Effects
Nausea, vomiting common. Contraindicated in MTC/MEN 2.
Studies
SCALE Obesity Trial (liraglutide 3.0 mg)
Liraglutide 3.0 mg daily plus lifestyle produced 8.0% weight loss over 56 weeks versus 2.6% with placebo.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.